Location History:
- Leioa, ES (2010)
- Leioa-Vizcaya, ES (2011 - 2013)
Company Filing History:
Years Active: 2010-2013
Title: Innovations of Carlos Matute Almau
Introduction
Carlos Matute Almau is a notable inventor based in Leioa-Vizcaya, Spain. He has made significant contributions to the field of neuroprotection and demyelinating diseases through his innovative patents. With a total of two patents to his name, Matute Almau's work focuses on the development of pharmaceutical compositions and diagnostic methods.
Latest Patents
One of his latest patents is titled "Compounds having neuroprotective properties." This invention relates to the use of morin and mangiferin, along with their pharmaceutically acceptable salts, prodrugs, and/or solvates, in creating a pharmaceutical composition aimed at preventing and treating neurodegenerative diseases and symptoms associated with aging. Additionally, he has developed food compositions that incorporate these compounds.
Another significant patent is "Method for the diagnosis and prognosis of demyelinating diseases." This invention utilizes glutamate transporters, glutamate, and EGF to detect the presence of demyelinating diseases in a subject. It also helps determine the status or severity of these diseases and monitor the effects of therapies administered to affected individuals. The methods and compounds described in this patent are particularly applicable to multiple sclerosis (MS).
Career Highlights
Carlos Matute Almau has worked with prestigious institutions such as the University of the Basque Country and Pablo de Olavide University. His research and innovations have contributed to advancements in the understanding and treatment of neurodegenerative conditions.
Collaborations
Throughout his career, Matute Almau has collaborated with notable colleagues, including Maria Victoria Sanchez Gomez and Rosario Campos Esparza. These partnerships have further enriched his research endeavors and innovations.
Conclusion
Carlos Matute Almau is a distinguished inventor whose work in neuroprotection and demyelinating diseases has led to valuable patents. His contributions continue to impact the field of medical research and pharmaceutical development.